Targeting dendritic cells with TLR-2 ligand–coated nanoparticles loaded with Mycobacterium tuberculosis epitope induce antituberculosis immunity
Author(s) -
Deepjyoti Kumar Das,
Mohammad Adeel Zafar,
Sidhanta Nanda,
Sanpreet Singh,
Taruna Lamba,
Hilal Bashir,
Pargat Singh,
Sudeep K. Maurya,
Sajid Nadeem,
Sharvan Sehrawat,
Vijayender Bhalla,
Javed N. Agrewala
Publication year - 2022
Publication title -
journal of biological chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.361
H-Index - 513
eISSN - 1067-8816
pISSN - 0021-9258
DOI - 10.1016/j.jbc.2022.102596
Subject(s) - cd80 , cd86 , mycobacterium tuberculosis , proinflammatory cytokine , immunology , dendritic cell , tuberculosis , vaccination , toll like receptor , tumor necrosis factor alpha , immune system , biology , microbiology and biotechnology , innate immune system , medicine , cytotoxic t cell , t cell , inflammation , cd40 , biochemistry , pathology , in vitro
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom